These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23152005)

  • 1. Current status of DILD in molecular targeted therapies.
    Saito Y; Gemma A
    Int J Clin Oncol; 2012 Dec; 17(6):534-41. PubMed ID: 23152005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of Time-to-onset of Interstitial Lung Disease after the Administration of Small Molecule Molecularly-targeted Drugs].
    Komada F
    Yakugaku Zasshi; 2018; 138(2):229-235. PubMed ID: 29386436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interstitial lung disease associated with chemotherapy and molecularly-targeted drug: diagnosis and management].
    Saito Y; Gemma A
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2531-7. PubMed ID: 22189216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer.
    Sakurada T; Kakiuchi S; Tajima S; Horinouchi Y; Okada N; Nishisako H; Nakamura T; Teraoka K; Kawazoe K; Yanagawa H; Nishioka Y; Minakuchi K; Ishizawa K
    Ann Pharmacother; 2015 Apr; 49(4):398-404. PubMed ID: 25565405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world.
    Kaku S; Horinouchi H; Watanabe H; Yonemori K; Okusaka T; Boku N; Yamazaki N; Kawai A; Ohe Y; Kusumoto M
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1737-1746. PubMed ID: 35129672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-induced interstitial lung disease].
    Gemma A
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1668-70. PubMed ID: 18931568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced interstitial lung disease (DILD) in molecular targeted therapy.
    Gemma A
    Int J Clin Oncol; 2012 Dec; 17(6):533. PubMed ID: 23152006
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance study.
    Osawa M; Kudoh S; Sakai F; Endo M; Hamaguchi T; Ogino Y; Yoneoka M; Sakaguchi M; Nishimoto H; Gemma A
    Int J Clin Oncol; 2015 Dec; 20(6):1063-71. PubMed ID: 25967287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiological Patterns of Drug-induced Interstitial Lung Disease (DILD) in Early-phase Oncology Clinical Trials.
    Terbuch A; Tiu C; Candilejo IM; Scaranti M; Curcean A; Bar D; Estevez Timon M; Ameratunga M; Ang JE; Ratoff J; Minchom AR; Banerji U; de Bono JS; Tunariu N; Lopez JS
    Clin Cancer Res; 2020 Sep; 26(18):4805-4813. PubMed ID: 32332017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of Time-to-onset and Onset-pattern of Interstitial Lung Disease after the Administration of Monoclonal Antibody Agents].
    Komada F; Nakayama Y; Takara K
    Yakugaku Zasshi; 2018; 138(12):1587-1594. PubMed ID: 30504674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HLA-DRB1*04:05 allele with drug-induced interstitial lung disease in Japanese population.
    Imatoh T; Ushiki A; Ota M; Ito M; Sekine A; Yamashita T; Mashimo Y; Nakamura R; Saito K; Saito Y; Hanaoka M
    Pharmacogenomics J; 2020 Dec; 20(6):823-830. PubMed ID: 32467566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case-control study.
    Jo T; Michihata N; Yamana H; Morita K; Ishimaru M; Yamauchi Y; Hasegawa W; Urushiyama H; Uda K; Matsui H; Fushimi K; Yasunaga H; Nagase T
    Thorax; 2021 Dec; 76(12):1193-1199. PubMed ID: 33888574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expert consensus on the diagnosis and treatment of anticancer drug-induced interstitial lung disease].
    Anticancer Drug-induced Interstitial Lung Disease Management Group
    Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):693-702. PubMed ID: 35880334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug induced interstitial lung disease in oncology phase I trials.
    Yonemori K; Hirakawa A; Kawachi A; Kinoshita F; Okuma H; Nishikawa T; Tamura K; Fujiwara Y; Takebe N
    Cancer Sci; 2016 Dec; 107(12):1830-1836. PubMed ID: 27685762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of Patients With Interstitial Lung Disease Induced by Different Pharmacological Types of Anticancer Drugs.
    Iwashita K; Mizuno T; Kumazawa S; Imaizumi K; Yamada S
    Anticancer Res; 2021 May; 41(5):2563-2568. PubMed ID: 33952484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced Interstitial Lung Disease Has the Same Degree of Risk for Mortality as Old Age in Patients With Lung Cancer.
    Iwashita K; Mizuno T; Kumazawa S; Imaizumi K; Yamada S
    Anticancer Res; 2021 Mar; 41(3):1707-1711. PubMed ID: 33788769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of Risk Factors for Side Effects and the Establishment of Supportive Therapy during Cancer Chemotherapy].
    Sakurada T
    Yakugaku Zasshi; 2018; 138(11):1363-1370. PubMed ID: 30381644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical best practices in optimal monitoring, early diagnosis, and effective management of antibody-drug conjugate-induced interstitial lung disease or pneumonitis: a multidisciplinary team approach in Singapore.
    Yong WP; Teo FS; Teo LL; Ng MC; Tan TJ; Low SY; Wong K; Ang P; Choo SP; Lee KH; Lee SC
    Expert Opin Drug Metab Toxicol; 2022 Dec; 18(12):805-815. PubMed ID: 36636012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer.
    Kato T; Masuda N; Nakanishi Y; Takahashi M; Hida T; Sakai H; Atagi S; Fujita S; Tanaka H; Takeda K; Satouchi M; Namba Y; Tamura T
    Lung Cancer; 2017 Feb; 104():111-118. PubMed ID: 28212992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced interstitial lung diseases associated with molecular-targeted anticancer agents.
    Gemma A
    J Nippon Med Sch; 2009 Feb; 76(1):4-8. PubMed ID: 19305103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.